142 related articles for article (PubMed ID: 33643220)
1. Is Seed and Soil Theory Suitable for Metastatic Spread of Pituitary Carcinomas?
Dai C; Sun B; Kang J
Front Endocrinol (Lausanne); 2020; 11():607405. PubMed ID: 33643220
[No Abstract] [Full Text] [Related]
2. ACTH-secreting Crooke cell carcinoma of the pituitary.
Kovács GL; Góth M; Rotondo F; Scheithauer BW; Carlsen E; Saadia A; Hubina E; Kovács L; Szabolcs I; Nagy P; Czirják S; Hanzély Z; Kovács K; Horváth É; Korbonits M
Eur J Clin Invest; 2013 Jan; 43(1):20-6. PubMed ID: 23134557
[TBL] [Abstract][Full Text] [Related]
3. Concerning the article "Cushing's disease associated with both pituitary microadenoma and corticotroph hyperplasia".
Saeger W
Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):68. PubMed ID: 20127571
[No Abstract] [Full Text] [Related]
4. Carcinomas of the pituitary: definition and review of the literature.
Lübke D; Saeger W
Gen Diagn Pathol; 1995 Oct; 141(2):81-92. PubMed ID: 8548598
[TBL] [Abstract][Full Text] [Related]
5. Malignant prolactinoma: a rare case report.
Trivedi P; Gupta A; Pasricha S; Patel D
Neurol India; 2010; 58(5):778-80. PubMed ID: 21045511
[TBL] [Abstract][Full Text] [Related]
6. Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature.
Lizzul L; Lombardi G; Barbot M; Ceccato F; Gardiman MP; Regazzo D; Bellu L; Mazza E; Losa M; Scaroni C
Pituitary; 2020 Aug; 23(4):359-366. PubMed ID: 32232709
[TBL] [Abstract][Full Text] [Related]
7. Metastasis to pituitary adenoma: case report and review of the literature.
Hoellig A; Niehusmann P; Flacke S; Kristof RA
Cent Eur Neurosurg; 2009 Aug; 70(3):149-53. PubMed ID: 19701874
[TBL] [Abstract][Full Text] [Related]
8. Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience.
Raverot G; Sturm N; de Fraipont F; Muller M; Salenave S; Caron P; Chabre O; Chanson P; Cortet-Rudelli C; Assaker R; Dufour H; Gaillard S; François P; Jouanneau E; Passagia JG; Bernier M; Cornélius A; Figarella-Branger D; Trouillas J; Borson-Chazot F; Brue T
J Clin Endocrinol Metab; 2010 Oct; 95(10):4592-9. PubMed ID: 20660056
[TBL] [Abstract][Full Text] [Related]
9. Pituitary carcinoma: a clinicopathologic study of 15 cases.
Pernicone PJ; Scheithauer BW; Sebo TJ; Kovacs KT; Horvath E; Young WF; Lloyd RV; Davis DH; Guthrie BL; Schoene WC
Cancer; 1997 Feb; 79(4):804-12. PubMed ID: 9024719
[TBL] [Abstract][Full Text] [Related]
10. Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas.
Lasolle H; Cortet C; Castinetti F; Cloix L; Caron P; Delemer B; Desailloud R; Jublanc C; Lebrun-Frenay C; Sadoul JL; Taillandier L; Batisse-Lignier M; Bonnet F; Bourcigaux N; Bresson D; Chabre O; Chanson P; Garcia C; Haissaguerre M; Reznik Y; Borot S; Villa C; Vasiljevic A; Gaillard S; Jouanneau E; Assié G; Raverot G
Eur J Endocrinol; 2017 Jun; 176(6):769-777. PubMed ID: 28432119
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal metastatic pituitary prolactinoma.
Rockwell BH; Pica R; Raji MR; Dastur KJ; Altschuler EM; Johnston JM
AJR Am J Roentgenol; 1996 Nov; 167(5):1295-6. PubMed ID: 8911199
[No Abstract] [Full Text] [Related]
12. Metastases to the Pituitary Gland: Histological Patterns of Spread and Review of the Literature.
Kleinschmidt-DeMasters BK
J Neuropathol Exp Neurol; 2021 Nov; 80(11):1033–1042. PubMed ID: 34559240
[TBL] [Abstract][Full Text] [Related]
13. [Pituitary carcinoma. Anatomic and clinical features of cases reported in literature].
Sidibé EH
Neurochirurgie; 2007 Aug; 53(4):284-8. PubMed ID: 17524431
[TBL] [Abstract][Full Text] [Related]
14. Role of matrix metalloproteinase 9 in pituitary tumor behavior.
Turner HE; Nagy Z; Esiri MM; Harris AL; Wass JA
J Clin Endocrinol Metab; 2000 Aug; 85(8):2931-5. PubMed ID: 10946906
[TBL] [Abstract][Full Text] [Related]
15. Pituitary carcinoma.
Ciric IS
World Neurosurg; 2013 Nov; 80(5):e147-9. PubMed ID: 22082969
[No Abstract] [Full Text] [Related]
16. A case of prolactin-secreting pituitary carcinoma and its histological findings.
Noda M; Suzuki R; Moriya M; Itokawa H; Asai J; Nagashima G; Fujimoto T
Brain Tumor Pathol; 2004; 21(3):149-54. PubMed ID: 15696977
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of dopamine D2 receptors in human pituitary adenomas.
Pawlikowski M
Folia Histochem Cytobiol; 2010 Sep; 48(3):394-7. PubMed ID: 21071344
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic prolactin cell hyperplasia of the pituitary mimicking prolactin cell adenoma: a morphological study including immunocytochemistry, electron microscopy, and in situ hybridization.
Jay V; Kovacs K; Horvath E; Lloyd RV; Smyth HS
Acta Neuropathol; 1991; 82(2):147-51. PubMed ID: 1927271
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors.
Chen Y; Gao H; Liu Q; Xie W; Li B; Cheng S; Guo J; Fang Q; Zhu H; Wang Z; Wang J; Li C; Zhang Y
Aging (Albany NY); 2020 Dec; 13(1):1422-1439. PubMed ID: 33472171
[TBL] [Abstract][Full Text] [Related]
20. Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies.
Raverot G; Jouanneau E; Trouillas J
Eur J Endocrinol; 2014 Apr; 170(4):R121-32. PubMed ID: 24431196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
